United States Orthobiologics Market Outlook to 2025

United States Orthobiologics Market Outlook to 2025


  • Products Id :- GDMECC3125DB
  • |
  • Pages: 213
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

United States Orthobiologics Market Outlook to 2025

Summary

GlobalData's new report, United States Orthobiologics Market Outlook to 2025, provides key market data on the United States Orthobiologics market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market categories-Bone Grafts and Substitutes, Bone Growth Stimulators, Soft Tissue Biologics and Viscosupplementation.

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size and company share data for Orthobiologics market categories-Bone Grafts and Substitutes, Bone Growth Stimulators, Soft Tissue Biologics and Viscosupplementation.

- Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2015 to 2025.

- 2017 company share and distribution share data for Orthobiologics market.

- Global corporate-level profiles of key companies operating within the United States Orthobiologics market.

- Key players covered include Medtronic plc, Sanofi, Stryker Corp and Others.

Reasons to buy

- Develop business strategies by identifying the key market categories poised for strong growth in the future.

- Develop market-entry and market expansion strategies.

- Design competition strategies by identifying who-stands-where in the market.

- Develop investment strategies by identifying the key market categories expected to register strong growth in the near future.

- What are the key distribution channels and what's the most preferred mode of product distribution-Identify, understand and capitalize.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 3

1.2 List of Figures 3

2 Introduction 5

2.1 What Is This Report About? 5

2.2 OrthobiologicsMarket Segmentation 5

2.3 Definitions of Markets Covered in the Report 6

3 Orthobiologics Market, United States 9

3.1 Orthobiologics Market, United States, Revenue (USDm), 2015-2025 9

3.2 Orthobiologics Market, United States, Volume (Units), 2015-2025 20

3.3 Orthobiologics Market, United States, Average Price (USD), 2015-2025 32

3.4 Orthobiologics Market, United States, Distribution Share by Revenue (USDm), 2017 34

3.5 Orthobiologics Market, United States, Company Share by Revenue (USDm), 2017 35

4 Overview of Key Companies in United States, Orthobiologics Market 37

4.1 Medtronic Plc 37

4.2 Sanofi 37

4.3 DePuy Synthes Inc 37

4.4 Anika Therapeutics Inc 37

4.5 Fidia farmaceutici SpA 38

4.6 Stryker Corp 38

4.7 Zimmer Biomet Holdings Inc 38

4.8 DJO Global Inc 39

4.9 Seikagaku Corp 39

4.10 ConMed Corporation 39

4.11 LifeNet Health Inc 39

4.12 RTI Surgical Inc 40

4.13 Orthofix Holdings Inc 40

4.14 Bioventus LLC 40

4.15 Ferring Pharmaceuticals A/S 40

4.16 SeaSpine, Inc. 41

5 Orthobiologics Market Pipeline Products 42

6 Financial Deals Landscape 44

6.1 Debt Offerings 44

6.2 Equity Offerings 47

6.3 Partnerships 62

6.4 Private Equity 63

6.5 Venture Financing 66

7 Recent Developments 68

7.1 Corporate Communications 68

7.2 Financial Announcements 91

7.3 Government and Public Interest 176

7.4 Legal And Regulatory 178

7.5 Other Significant Developments 183

7.6 Product News 195

7.7 Strategy And Business Planning 199

8 Appendix 202

8.1 Research Methodology 203

8.2 GlobalData Consulting 207

8.3 Contact Us 208

8.4 Disclaimer 208

1.2 List of Figures

Figure 1: Orthobiologics Market, United States, Revenue (USDm), USD Constant, 2015-2025 14

Figure 2: Bone Grafts and Substitutes Market, United States, Revenue (USDm), USD Constant, 2015-2025 16

Figure 3: Bone Growth Stimulators Market, United States, Revenue (USDm), USD Constant, 2015-2025 19

Figure 4: Soft Tissue Biologics Market, United States, Revenue (USDm), USD Constant, 2015-2025 21

Figure 5: Viscosupplementation Market, United States, Revenue (USDm), USD Constant, 2015-2025 23

Figure 6: Orthobiologics Market, United States, Volume (Units), 2015-2025 25

Figure 7: Bone Grafts and Substitutes Market, United States, Volume (Units), 2015-2025 28

Figure 8: Bone Growth Stimulators Market, United States, Volume (Units), 2015-2025 31

Figure 9: Soft Tissue Biologics Market, United States, Volume (Units), 2015-2025 33

Figure 10: Viscosupplementation Market, United States, Volume (Units), 2015-2025 35

Figure 11: Orthobiologics Market, United States, Company Share (%) 2017 40

1.1 List of Tables

Table 1: Orthobiologics Market, United States, Revenue (USDm), USD Constant, 2015-2020 15

Table 2: Orthobiologics Market, United States, Revenue (USDm), USD Constant, 2021-2025 15

Table 3: Bone Grafts and Substitutes Market, United States, Revenue (USDm), USD Constant, 2015-2020 17

Table 4: Bone Grafts and Substitutes Market, United States, Revenue (USDm), USD Constant, 2021-2025 18

Table 5: Bone Growth Stimulators Market, United States, Revenue (USDm), USD Constant, 2015-2020 20

Table 6: Bone Growth Stimulators Market, United States, Revenue (USDm), USD Constant, 2021-2025 20

Table 7: Soft Tissue Biologics Market, United States, Revenue (USDm), USD Constant, 2015-2020 22

Table 8: Soft Tissue Biologics Market, United States, Revenue (USDm), USD Constant, 2021-2025 22

Table 9: Viscosupplementation Market, United States, Revenue (USDm), USD Constant, 2015-2020 24

Table 10: Viscosupplementation Market, United States, Revenue (USDm), USD Constant, 2021-2025 24

Table 11: Orthobiologics Market, United States, Volume (Units), 2015-2020 26

Table 12: Orthobiologics Market, United States, Volume (Units), 2021-2025 27

Table 13: Bone Grafts and Substitutes Market, United States, Volume (Units), 2015-2020 29

Table 14: Bone Grafts and Substitutes Market, United States, Volume (Units), 2021-2025 30

Table 15: Bone Growth Stimulators Market, United States, Volume (Units), 2015-2020 32

Table 16: Bone Growth Stimulators Market, United States, Volume (Units), 2021-2025 32

Table 17: Soft Tissue Biologics Market, United States, Volume (Units), 2015-2020 34

Table 18: Soft Tissue Biologics Market, United States, Volume (Units), 2021-2025 34

Table 19: Viscosupplementation Market, United States, Volume (Units), 2015-2020 36

Table 20: Viscosupplementation Market, United States, Volume (Units), 2021-2025 36

Table 21: Orthobiologics Market, United States, Average Price (USD), 2015-2020 37

Table 22: Orthobiologics Market, United States, Average Price (USD), 2021-2025 38

Table 23: Orthobiologics Market, United States, Distribution Share by Revenue (USDm), USD Constant, 2017 39

Table 24: Orthobiologics Market, United States, Company Share by Revenue (USDm), USD Constant, 2017 41

Table 25: Orthobiologics Market Pipeline Products 47

Table 26: Bone Biologics to Raise up to USD2 Million in Private Placement of 8.5% Notes Due 2019 49

Table 27: Bone Biologics Raises USD0.7 Million in First Tranche of Private Placement of 8.5% Convertible Promissory Note Due 2017 50

Table 28: Bone Biologics to Raise USD3.7 Million in Private Placement of Shares 52

Table 29: PolarityTE Prices Public Offering of Shares for USD55 Million 53

Table 30: Vericel Raises USD74.8 Million in Public Offering of Shares 54

Table 31: Integra LifeSciences Prices Public Offering of Shares for USD307 Million 56

Table 32: Alphatec Holdings Plans to Raise Funds through Public Offering of Shares 58

Table 33: PolarityTE Raises USD37.3 Million in Public Offering of Shares 59

Table 34: Histogenics Raises USD6.3 Million in Public Offering of Shares 61

Table 35: Ortho Regenerative Technologies Raises Funds through Private Placement of Shares and Warrants 63

Table 36: Alphatec Holdings Plans to Raise USD100 Million in Public Offering of Shares 64

Table 37: Bone Biologics Raises USD0.7 Million in First Tranche of Private Placement of Shares 65

Table 38: CellRight Technologies Enters into Distribution Agreement with Arthrex 67

Table 39: TPG Capital Amends Agreement to Acquire Exactech 68

Table 40: JANA Partners Denies Rumor to Acquire Certain Stake in Zimmer Biomet 70

Table 41: Carmell Therapeutics Raises USD0.4 Million in Financing 71

Table 42: Nanovis Raises USD0.7 Million in Financing 72

Table 43: Total Number of Primary Research Participants, Orthopedic Devices Market, by Country 210

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Medtronic Plc

Sanofi

DePuy Synthes Inc

Anika Therapeutics Inc

Fidia farmaceutici SpA

Stryker Corp

Zimmer Biomet Holdings Inc

DJO Global Inc

Seikagaku Corp

ConMed Corporation

LifeNet Health Inc

RTI Surgical Inc

Orthofix Holdings Inc

Bioventus LLC

Ferring Pharmaceuticals A/S

SeaSpine, Inc.

Orthopedic Devices, Arthroscopy Devices, Cranio Maxillofacial Fixation (CMF), Hip Reconstruction, Knee Reconstruction, Orthobiologics, Orthopedic Bone Cement and Casting Materials, Orthopedic Power Tools, Orthopedic Prosthetics, Orthotic Devices, Other Joint Reconstruction, Spinal Surgery, Trauma Fixation, Value (USD), Volume (units), Revenues, Average Price, Company Share, Distribution Share by Revenue, Company Share by Revenue, Pipeline Products, News, Deals, Key Companies, DePuy Synthes Inc, Zimmer Biomet Holdings Inc, Stryker Corp, Otto GmbH & Co KG, Medtronic plc, Smith & Nephew Plc, Ossur hf, Arthrex Inc, DJO Global Inc, e-life International Co., Ltd. Essity Aktiebolag

select a license
Single User License
USD 4995 INR 342757
Site License
USD 9990 INR 685514
Corporate User License
USD 14985 INR 1028271

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com